WST Deadline: WST Investors with Losses in Excess of $100K Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit

NEW YORK, June 15, 2025 /PRNewswire/ —
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the 'Class Period'), of the important July 7, 2025 lead plaintiff deadline.
So what: If you purchased West Pharmaceutical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
What to do next: To join the West Pharmaceutical class action, go to https://rosenlegal.com/submit-form/?case_id=39367 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 7, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin High-Value Products ('HVP') portfolio; (2) West's SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to West's profit margins due to operational inefficiencies; (3) these margin pressures created the risk of costly restructuring activities, including West's exit from continuous glucose monitoring ('CGM') contracts with long-standing customers; and (4) as a result of the foregoing, defendants' positive statements about West's business, operations, and prospects were materially false and/or misleading or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the West Pharmaceutical class action, go to https://rosenlegal.com/submit-form/?case_id=39367 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) 202-3827case@rosenlegal.comwww.rosenlegal.com

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Malaysian Reserve

2 hours ago

• Malaysian Reserve

NYSE Content Advisory: Pre-Market update + Wall Street reopens after Juneteenth

NEW YORK, June 20, 2025 /CNW/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on June 20th Traders return to Wall Street this morning following the Juneteenth Holiday for the final day of trading this week. Stocks are down fractionally early Friday and are little changed on the week. Equities had a mixed session Wednesday after the Federal Reserve kept interest rates unchanged. Following the decision, Fed Chair Powell said the central bank is 'well-positioned to wait' before lowering rates. On Thursday, White House Press Secretary Karoline Leavitt said that President Trump will decide if the U.S. will get involved in the Middle East conflict over the next two weeks. Opening BellZERO Prostate Cancer & Novartis (NYSE: NVS) commemorate Men's Health Month Closing BellAmerican Integrity (NYSE: AII) celebrates the launch of its IPO Click here to download the NYSE TV App

The Star

3 hours ago

• The Star

East African fashion life show opens in Kenya to boost textiles, apparels trade

NAIROBI, June 20 (Xinhua) -- The second edition of East Africa (Kenya) Fashion Life Show was officially opened on Friday in Nairobi, the Kenyan capital, drawing over 70 exhibitors from Kenya and China. Chinese enterprises are exhibiting textiles, packaging material, baby toys, personal care products and wigs, home decor, and gift wrappers during the expo that runs from Thursday to Saturday. Yin Maolin, Party chief of Mudan District in Heze City, east China's Shandong Province, led a high-level Chinese delegation to attend the expo that will highlight the potential of East Africa as a hub for the fashion, sustainable textile, and apparel sector. According to Yin, the fashion show offers a platform for deepening economic partnership between China and Kenya, focusing on trade in high-quality manufactured products and jointly establishing seamless supply chains. Pius Rotich, general manager for investment promotion and business development services at Kenya Investment Authority, said the government has created a conducive policy and regulatory environment to spur the growth of the textile and apparel sector. Kenya is committed to a partnership with Chinese investors in a bid to manufacture high-quality leather products for export in the African market and beyond, boosting foreign exchange earnings and job creation, said Rotich. Gao Wei, managing director of Afripeak Expo Kenya Ltd., co-organizer of the 2025 East African Fashion Show, said this year's edition had grown bigger in terms of the number of visitors and exhibitors, reaffirming dynamism in the region's textile and apparel sectors. The fashion expo, according to Gao, will run under the theme of "Inspire Friendship, Connect World," bringing together Chinese and Kenyan enterprises dealing with household accessories, cosmetics, and electronics under one roof. Gao said the expo will also create a platform for Chinese business executives to network with their Kenyan counterparts, explore two-way trade in leather products. Hundreds of Kenyan visitors thronged to the East Africa Fashion expo, with the majority acknowledging their appreciation of Chinese-made products, including wigs, cosmetics and fabrics. Waceke Mwaura, a female entrepreneur, said that she was impressed by the wig showcased by Chinese exhibitors, adding that its high quality has made it popular among local clients. Mwaura said she has been importing hair from China to supply to local retailers and beauty parlors, even as she scouts for distributorship arrangements with Chinese manufacturers. Paul Munyua, a middle-aged pedicurist, said that he visited the expo to gain insight into new beauty products in the local market imported from China that are affordable to his clients.

New Straits Times

4 hours ago

• New Straits Times

A-GC denies flawed prosecution in Najib's SRC case, cites evidence constraints

KUALA LUMPUR: The Attorney-General's Chambers (A-GC) has refuted claims that the prosecution in the money laundering case involving funds from SRC International Sdn Bhd (SRC) was flawed. In a statement, the A-GC said it has consistently upheld the highest standards and quality in discharging its prosecutorial duties, in line with public expectations. "The A-GC remains committed to upholding the rule of law and will continue to carry out its responsibilities under the Federal Constitution with integrity, fairness and respect for judicial processes," the statement read. The statement followed the High Court's decision to grant a discharge not amounting to an acquittal (DNAA) to former prime minister Datuk Seri Najib Razak over three money laundering charges involving RM27 million linked to SRC. High Court Judge K. Muniandy issued the ruling today after the prosecution failed to furnish the defence with hundreds of documents related to the trial, despite the charges being filed as early as 2019. Addressing the delay in trial proceedings, the A-GC said the case, first registered at the High Court in February 2019, was postponed on five occasions due to various factors, including the Covid-19 pandemic, defence requests and applications by the prosecution itself. The A-GC said that proceedings for the 1Malaysia Development Bhd (1MDB) trial had commenced while the first SRC case was still ongoing at the High Court, Court of Appeal and Federal Court levels. This overlap led to delays in the second SRC trial, as both cases involved the use of key material documents required for the prosecution, it said. Following this, it said, there was no choice but to wait until the documents were made available. "Both cases involved the use of certain material documents that were also intended to be used in the second SRC trial. "As the documents in question are material to the second SRC trial, the prosecution had no choice but to wait until those documents became available, which is after the 1MDB trial proceedings have concluded. "It must be emphasised that the material documents are already available but are currently being used as evidence in the ongoing 1MDB trial," it said. The A-GC also said the prosecution had requested additional time to compile all the material documents to present them as evidence in the second SRC trial.